Inhibitor of protein kinase D (PKD) for use in prevention or treatment of obesity and a pharmaceutical composition for such use
Patent inventors: Grzegorz Sumara, Jonathan TrujilloViera

Description of the invention will be available after the patent application is published.

The Nencki Institute is a co-applicant of the patent with University of Würzburg.

For more information contact Technology Transfer Office.

Application number:
EP21461519.7 and P.437178 (03.03.2021), PCT/IB2022/051895 (03.03.2022)
Patent status: